Covaxin looks like the only option for India, which is currently facing a lot in terms of the pandemic. The disease is spreading like wildfire in the country. The initial phases of the lockdown helped control the disease to an extent. But, after the announcement of “Unlock 1” from Prime Minister Narendra Modi, the extent of the disease kept increasing.
India recorded around 18,532 new coronavirus cases on 30 June 2020 which takes the overall count to 585,197 according to the figures by the health ministry. The toll from the disease rose by 418 to 17,410. Over 347,802 people have recovered so far.
Coronavirus cure: Bharat Biotech’s Covaxin will help India
The Drug Control General of India has given its final approval to Bharat Biotech in order to conduct human clinical trials of a potential Coronavirus vaccine. Covaxin, developed in collaboration with the National Institute of Virology and the Indian Council of Medical Research, will be clinically tested across the country from next month.
External Affairs Minister S Jaishankar discussed the coronavirus crisis with his French counterpart Jean-Yves Le Drian in a meeting today.
Wide-ranging discussion with French FM @JY_LeDrian. Covered issues of contemporary security and political importance. Also agreed to address #COVID-related challenges in health and aviation. Thanked him for the strong support in #UNSC and look forward to working together.
— Dr. S. Jaishankar (@DrSJaishankar) June 30, 2020
Currently, almost 30 national institutions are working to develop a cure Coronavirus. This project helps to look at the problem from a different view. The research helps to produce specific human monoclonal antibodies that are capable of killing the SARS-CoV-2 virus. These kinds of virus-neutralizing antibodies help block the rapid spread of the infection. This is a very effective, cheap, and safe method to kill COVID-19.
Bharat Biotech is currently trying with the cure very fast, and Covaxin might be the answer for all of it. Let us know what you have to say about this in the comments section below! Also, don’t forget to join us on our Telegram Channel for more such latest updates and discussions.